Publication | Closed Access

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma

Hematological MalignancyPrognostic MarkerLymphoid NeoplasiaSerum Deoxythymidine KinaseMedicineMalignant Blood DisorderHematologyPathologyOncologyCancer ResearchMolecular Oncology